LOGO
Print this page | Exit  
ASTHMA AND COPD: MECHANISM OF ACTION OF GLUCOCORTICOIDS, β2-AGONISTS AND THEIR COMBINATION
mainBullet
 
mainBullet
Introduction
 
mainBullet
 
Glucocorticosteroids mechanism of action
 
mainBullet
mainBullet
mainBullet
mainBullet
 

 

Inhaled Glucocorticosteroids (ICSs) > Glucocorticosteroids mechanism of action
Glucocorticosteroids mechanism of action

Glucocorticoids biological effects are mediated by specific intracellular receptors (Glucocorticoid Receptors, GRs), which, in the lungs, are mainly localised in the airway epithelial and endothelial cells, where they are assumed to mediate the anti-inflammatory actions of ICSs.

Under resting conditions, inactive GRs are located in the cytosol, associated with multiple chaperone proteins (which are proteins required for the proper folding or assembly of another protein or protein complex without being a component of the final structure).

After having penetrated the cell membrane, glucocorticoid molecules bind to GRs, inducing their dissociation from chaperones and the consequent formation of active GR-glucocorticoid complexes, which may act in three different ways (Fig. 2).3

Figure 2: General mechanism of action of glucocorticoids (Adapted from NEJM 2005; 353: 1711-1723).3

  • DIRECT GENOMIC PATHWAY: The GR-glucocorticoid complex moves to the cell nucleus where it binds as a homodimer (a complex of two identical protein chains held together by non-covalent/weak bonds) to specific DNA sequences called glucocorticoid-responsive elements (GREs). The resulting complex recruits either co-activator or co-repressor proteins that consequently facilitate or inhibit gene transcription by RNA polimerase II. This process is called trans-activation and determines direct genomic effects.

  • INDIRECT GENOMIC PATHWAY: Alternatively, the active GR-glucocorticoid complex may also act as a monomer and directly interact with other transcription factors, such as nuclear factor (NF)-kB, which is mainly involved in the DNA acetylation and unwinding process due to proinflammatory cytokines: inhibiting this transcription factors activity the related proinflammatory process is blocked. This process is termed trans-repression and induces indirect genomic effects.

  • NON-GENOMIC PATHWAY: Furthermore, glucocorticoid signalling can also be mediated by membrane associated receptors and second messengers (indicated as non-genomic pathway), which lead to the induction of anti-inflammatory proteins as well.

Glucocorticoids reduce inflammation through all these three mechanisms.

IMI logo